These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6438839)

  • 21. Methods of assessing factor VIII content of stored fresh frozen plasma intended for preparation of factor VIII concentrates.
    Smith JK; Snape TJ; Haddon ME; Gunson HH; Edwards R
    Transfusion; 1978; 18(5):530-7. PubMed ID: 705857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cryoprecipitated anti-hemophiliac factor manufactured from plasma frozen within 24 h after phlebotomy meets AABB quality standards.
    Lokhandwala PM; Young PP; White J; Brown BL
    Transfusion; 2022 Sep; 62(9):1731-1735. PubMed ID: 35894539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting the quality of cryoprecipitate.
    Subramaniyan R; Marwaha N; Jain A; Ahluwalia J
    Asian J Transfus Sci; 2017; 11(1):33-39. PubMed ID: 28316438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of small molecular forms of Factor VIII/von Willebrand factor from plasma.
    Perret BA; Furlan M; Beck EA
    Haemostasis; 1984; 14(4):289-95. PubMed ID: 6437941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased yield of F VIII from pooled plasma vs. single-donor plasma in the production of cryoprecipitates.
    Rácz Z; Thék M; Jánossy A; Pintér J; Baróti C
    Arch Med Res; 1997; 28(2):179-82. PubMed ID: 9204605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small-pool high-yield factor VIII production.
    Smit Sibinga CT
    Crit Rev Clin Lab Sci; 1986; 24(1):43-70. PubMed ID: 3098500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The recovery of factor VIII from fresh-frozen indated and outdated human plasma.
    Whitman DE; Switzer ME; McKee PA
    Thromb Haemost; 1976 Aug; 36(1):71-7. PubMed ID: 1036829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An improved thaw-siphon method for the cryoprecipitate preparation.
    Kang EP
    Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of whole blood processing and freezing conditions on the quality of therapeutic plasma prepared from whole blood.
    Runkel S; Hitzler WE; Hellstern P
    Transfusion; 2015 Apr; 55(4):796-804. PubMed ID: 25371048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thawing of fresh-frozen plasma with a new microwave oven.
    Söhngen D; Kretschmer V; Franke K; Pelzer H; Walker WH
    Transfusion; 1988; 28(6):576-80. PubMed ID: 3194932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight.
    Cardigan R; Lawrie AS; Mackie IJ; Williamson LM
    Transfusion; 2005 Aug; 45(8):1342-8. PubMed ID: 16078924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC.
    Yazer MH; Triulzi DJ; Hassett AC; Kiss JE
    Transfusion; 2010 May; 50(5):1014-8. PubMed ID: 20003046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentrated antihemophilic factor (AHF) from outdated blood.
    Weaver RA; Gabriel DA; Langdell RD
    Transfusion; 1967; 7(3):168-73. PubMed ID: 6025692
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.
    Serrano K; Scammell K; Weiss S; Culibrk B; Levin E; Gyöngyössy-Issa M; Devine DV
    Transfusion; 2010 Feb; 50(2):344-53. PubMed ID: 19843287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shelf-life of bank blood and stored plasma with special reference to coagulation factors.
    Nilsson L; Hedner U; Nilsson IM; Robertson B
    Transfusion; 1983; 23(5):377-81. PubMed ID: 6414128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    Ratnoff OD; Kass L; Lang PD
    J Clin Invest; 1969 May; 48(5):957-62. PubMed ID: 5780204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of plasma segments for estimating factor VIII activity in pools of fresh frozen plasma.
    Ofosu FA; Smith LM; Blajchman MA; Campbell J; De Vries C; Wah P
    Vox Sang; 1987; 52(3):254-6. PubMed ID: 3111094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality control of recovered plasma for fractionation: an extensive Italian study.
    Grazzini G; Rossi G; Rafanelli D; Gambelli D; Farina C; Mori F; Zucchelli P; Marchiori G; Breda A; Liumbruno GM
    Transfusion; 2008 Jul; 48(7):1459-68. PubMed ID: 18435675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.